The Bettencourt Schueller Foundation reveals the varied and far-reaching list of the winners of its scientific prizes, which, with a total value of €1.9 million, are awarded for high-level biomedical research.
Inserm, with the help of its subsidiary Inserm Transfert, continues to rise in the 2014 rankings of French patent applicants issued by the European Patent Office (EPO)
Valérie Mazeau-Woynar succeeds Claire Giry at the head of Inserm’s Department of Partnerships and External Relations (DPRE). In this role, she will contribute to the implementation of Inserm’s institutional partnerships at regional, national, European and international level, at the behest of Directorate General, and in coordination with the Thematic Institutes.
The Inserm Grand Prix is awarded to Anne Dejean-Assémat, director of Inserm/Institut Pasteur Joint Unit 993 “Nuclear Organization and Oncogenesis,” for her entire body of research on the molecular and cellular mechanisms involved in the development of human cancers.
The Ebola epidemic is continuing to spread, particularly in West Africa. According to the latest report by the World Health Organisation (WHO) dated 17 October, 9,216 cases of Ebola have been recorded and 4,555 people have died of the virus. With the current situation of the Ebola epidemic, it quickly became necessary for French research to be mobilised rapidly.
At a ceremony in New York, held on 10 October 2014, Inserm received one the five honorable mentions of the 'Digital PR award' for its bilingual online press room, presse.inserm.fr, in the best 'Online Newsroom' category.